Penumbra Introduces Latest Stroke Thrombectomy Aspiration Technology at SNIS 2019
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Business Wire
Clinical Experience with Penumbra JET™ 7 Reperfusion Catheter with XTRA FLEX Technology to be Highlighted at Company-Sponsored Symposium MIAMI--(BUSINESS WIRE)--Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Penumbra System’s most advanced technology – the Penumbra JET 7 Reperfusion Catheter with XTRA FLEX technology – at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting in Miami. Penumbra JET 7 with XTRA FLEX technology is used with the Penumbra ENGINE™ in the fully integrated Penumbra System® – an aspiration-based mechanical thrombectomy system that enables physicians to extract thrombus in acute ischemic stroke patients.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190722005174/en/Penumbra JET™ 7 with XTRA FLEX technology and Penumbra ENGINE™ (Photo: Business Wire)The Penumbra JET 7 Reperfusion Catheter w
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Truist Financial Co. from $240.00 to $285.00. They now have a "buy" rating on the stock.MarketBeat
- Penumbra, Inc. (NYSE: PEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $275.00 price target on the stock.MarketBeat
- Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Citigroup Inc. from $220.00 to $245.00. They now have a "neutral" rating on the stock.MarketBeat
- Penumbra, Inc. (NYSE: PEN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $275.00 price target on the stock, up previously from $190.00.MarketBeat
- Penumbra, Inc. (NYSE: PEN) had its price target raised by analysts at Canaccord Genuity Group Inc. from $260.00 to $323.00. They now have a "buy" rating on the stock.MarketBeat
PEN
Earnings
- 10/30/24 - Beat
PEN
Sec Filings
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- 12/17/24 - Form 4
- PEN's page on the SEC website